| P50 | author | Paris Vogazianos | Q64019407 |
| | Athos Antoniades | Q82551128 |
| | Marios Tomazou | Q88282175 |
| | Christos Shammas | Q90473202 |
| P2093 | author name string | Irina Zakharova | |
| | Elena Kamilari | |
| | Elpiniki Nikolaou | |
| | Artemy Sergeev | |
| | Dragana Savkov | |
| P2860 | cites work | Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells | Q21198789 |
| | Enterotypes of the human gut microbiome | Q24489818 |
| | Enterobacter spp.: pathogens poised to flourish at the turn of the century | Q24683746 |
| | Antibiotic use and its consequences for the normal microbiome | Q26749112 |
| | The intestinal microbiome in early life: health and disease | Q26996343 |
| | Antibiotics, pediatric dysbiosis, and disease | Q28080536 |
| | Gut microbiota: its role in hepatic encephalopathy | Q28084576 |
| | Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease | Q28143405 |
| | Rationale for the luminal provision of butyrate in intestinal diseases | Q28143911 |
| | Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms | Q28730663 |
| | Causality of small and large intestinal microbiota in weight regulation and insulin resistance | Q28828501 |
| | Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB | Q29547254 |
| | Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy | Q29547619 |
| | Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation | Q29617796 |
| | Members of the human gut microbiota involved in recovery from Vibrio cholerae infection | Q30394045 |
| | Individual Comparisons of Grouped Data by Ranking Methods | Q33730513 |
| | The treatment-naive microbiome in new-onset Crohn's disease | Q33762817 |
| | Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. | Q33995488 |
| | Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. | Q34326478 |
| | Diversity of human small intestinal Streptococcus and Veillonella populations | Q34341082 |
| | The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism | Q34355154 |
| | A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis | Q34369987 |
| | Butyrate production from dietary fibre and protection against large bowel cancer in a rat model | Q34376463 |
| | Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis | Q34408893 |
| | Rethinking "enterotypes". | Q34442627 |
| | In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects | Q34576551 |
| | Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? | Q34943068 |
| | The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs | Q34977818 |
| | Infant antibiotic exposure and the development of childhood overweight and central adiposity. | Q35205002 |
| | Gut microbial succession follows acute secretory diarrhea in humans | Q35635816 |
| | Structure and function of the healthy pre-adolescent pediatric gut microbiome | Q35755078 |
| | Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children | Q35904758 |
| | Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids | Q36209781 |
| | Multivariate analysis of functional metagenomes. | Q36748609 |
| | Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India | Q36932052 |
| | Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients | Q37118457 |
| | Enterococcus durans EP1 a Promising Anti-inflammatory Probiotic Able to Stimulate sIgA and to Increase Faecalibacterium prausnitzii Abundance | Q37634649 |
| | Antibiotics, birth mode, and diet shape microbiome maturation during early life. | Q37641944 |
| | Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents | Q37712802 |
| | Long-term impacts of antibiotic exposure on the human intestinal microbiota | Q37779673 |
| | Azithromycin--review of key chemical, pharmacokinetic and microbiological features | Q37884870 |
| | Antibiotic Use in Children - A Cross-National Analysis of 6 Countries | Q39066713 |
| | Multidrug resistance pattern of bacterial agents isolated from patient with chronic sinusitis | Q39625576 |
| | Effects of Probiotics, Prebiotics, and Synbiotics on Human Health | Q40044003 |
| | Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India. | Q40072867 |
| | Phaeohyphomycotic cyst caused by a recently described species, Phaeoannellomyces elegans | Q40190218 |
| | Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial | Q40246188 |
| | Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection | Q40913091 |
| | Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. | Q41049595 |
| | The interaction between Streptococcus spp. and Veillonella tobetsuensis in the early stages of oral biofilm formation | Q41280891 |
| | Lactulose, disaccharides and colonic flora. Clinical consequences | Q41494458 |
| | Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth | Q41863620 |
| | Azithromycin use in paediatrics: A practical overview | Q42151596 |
| | Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate | Q43714638 |
| | Bifidogenic effect and stimulation of short chain fatty acid production in human faecal slurry cultures by oligosaccharides derived from lactose and lactulose. | Q46007324 |
| | Association of Early-Life Antibiotic Use and Protective Effects of Breastfeeding: Role of the Intestinal Microbiota | Q46533510 |
| | Long-term ecological impacts of antibiotic administration on the human intestinal microbiota | Q46878665 |
| | Publisher Correction: Enterotypes in the landscape of gut microbial community composition | Q50025527 |
| | Fallacies inherent in the proband method of analysis of human pedigrees for inheritance of recessive traits; two methods of correction of the formula. | Q54372962 |
| | Predominant pathogens in hospital infections | Q54680963 |
| | The influence of antibiotics and dietary components on gut microbiota. | Q55715413 |
| | Drivers of Microbiome Biodiversity: A Review of General Rules, Feces, and Ignorance | Q57922438 |
| | Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial | Q59808479 |
| | Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial | Q60313071 |
| | Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children | Q60920960 |
| | Stereotypes About Enterotype: the Old and New Ideas | Q64096930 |
| | Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease | Q90684881 |
| | Lactulose: Patient- and dose-dependent prebiotic properties in humans | Q92600785 |
| P433 | issue | 2 | |
| P921 | main subject | azithromycin | Q165399 |
| | β-lactulose | Q422689 |
| P304 | page(s) | 168-176 | |
| P577 | publication date | 2019-10-03 | |
| P1433 | published in | World Journal of Pediatrics | Q15763275 |
| P1476 | title | Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose | |
| P478 | volume | 16 | |